Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Assays binding

The equilibrium dissociation constant, Ay, is a measure of binding affinity, defined as the free ligand concentration when 50% of the binding sites are occupied. It is equivalent to the ratio of the rate constants for dissociation and association, Ay = Arott/A on. Accordingly, the magnitude of Ay can be measured either at equilibrium, or as k0(flk0n. Several approaches have been used to measure these parameters in kinase drug discovery.34 Below, I outline some of the widely used methods. [Pg.107]

Binding assays usually offer a potentially important advantage over assays that require turnover of substrate—they can characterise the effects of test compounds against kinases in non-activated states, which frequently have low or undetectable levels of catalytic activity. However, binding alone may not [Pg.107]

Biosensor instruments such as Biacore (General Electric) exploit the sensitivity of a surface plasmon resonance response to the mass localised near the surface of a sensor chip. Various approaches can be used for kinases. Inhibition in solution assays involve immobilisation of a target definition compound (TDQ on the sensor surface.13,30 A buffer containing the kinase is flowed over the surface so that the protein is able to bind to the immobilised TDC, giving a signal. When test compounds are included in the buffer, they can compete for the TDC-kinase interaction, allowing estimation of Kd. [Pg.108]

Pyridinyl imidazoles have been used as fluorescent reporters of binding to p38a MAP kinase.12,13 To measure kon for test compounds, the kinase was [Pg.108]

The assay was utilized to measure zearlenone in food samples with a detection limit of 25 xM. [Pg.415]

MIP assays can also be utilized in synthetic organic applications. For example, MIP-based assays have been used to measure the chiral purity of samples in organic solvents. An L-phenylalanine anilide (l-PAA) imprinted polymer was utilized as a recognition element to measure the enantiomeric excess (ee) of PAA samples (Chen and Shimizu 2002). The MIP displays greater capacity for l-PAA versus d-PAA samples of similar concentration, and this difference was used to estimate enantiomeric excess. The enantiomeric excess of an unknown solution was determined by comparing the UV absorbance of the PAA remaining in solution after equilibration against a calibration curve. This MIP assay was demonstrated to be rapid and accurate with a standard error of +5% ee. [Pg.415]


There should be specific, saturable binding to the receptor, accompanied by pharmacological characteristics appropriate to the functional effects, demonstrable using a radioactive, eg, tritium or iodine-125, ligand to label the receptor. Radioligand binding assays (1,6) have become a significant means by which to identify and characterize receptors and enzymes (see Immunoassays Radioactive tracers). Isolation of the receptor or expression of the receptor in another cell, eg, an oocyte can be used to confirm the existence of a discrete entity. [Pg.517]

Enzyme Immunosensors. Enzyme immunosensors are enzyme immunoassays coupled with electrochemical sensors. These sensors (qv) require multiple steps for analyte determination, and either sandwich assays or competitive binding assays maybe used. Both of these assays use antibodies for the analyte of interest attached to a membrane on the surface of an electrochemical sensor. In the sandwich assay type, the membrane-bound antibody binds the sample antigen, which in turn binds another antibody that is enzyme-labeled. This immunosensor is then placed in a solution containing the substrate for the labeling enzyme and the rate of product formation is measured electrochemically. The rate of the reaction is proportional to the amount of bound enzyme and thus to the amount of the analyte antigen. The sandwich assay can be used only with antigens capable of binding two different antibodies simultaneously (53). [Pg.103]

It was agreed at the workshop that endocrine disrupting activity could only be adequately defined in terms of effects in intact animals, be they juvenile or adult, or in the offspring of exposed parents. For many chemicals, evidence of endocrine disrupting activity has been obtained only by the use of in vitro models, such as hormone binding assays. It was accepted, therefore, that chemicals active in such models should be considered only as potential EDs and should be distinguished from those established as active in vivo. For such chemicals, an alternative definition was recommended ... [Pg.4]

CD, TEM and a thioflavin binding assay (binding to fibrils results in a characteristic fluorescence emission) were used to confirm the existence of mixed fibrils (width roughly 20 nm, lengths ranging from hundreds of nanometres to several micrometres) prepared from the two peptides (pi6 and B2x-pl6) and consisting of p-sheets. [Pg.49]

Ansell, RJ Mosbach, K, Magnetic Molecularly Imprinted Polymer Beads for Drug Radioligand Binding Assay, Analyst 123, 1611, 1998. [Pg.608]

This approach can be generalized to all possible types of experimental data that may be generated. All chemical structures available in public databases or internal to a company typically feature at least the in vitro binding assay data and additionally, the three-dimensional structure of the protein and/or bound ligand. A chemical compound C will therefore be ... [Pg.335]

Binding assays for the saxitoxins were conducted with homogenized rabbit brain and saxitoxin exchange-labelled with tritium at C-11 (92, 93). If the various saxitoxins were available with suitably intense radiolabels, then the equilibrium dissociation constant, K, could be measured directly for each. Since only saxitoxin is currently available with the necessary label, the binding experiments instead measure the ability of a compound to compete with radiolabelled saxitoxin for the binding site. The value obtained, Kj, corresponds to the uilibrium dissociation constant, K, that would be observed for the compound if it were measured directly. Affinity is defined for this assay as the reciprocal of Kj. The affinities of several of the saxitoxins (94) are summarized in Figure 11, expressed relative to saxitoxin and plotted on a logarithmic scale. [Pg.53]


See other pages where Assays binding is mentioned: [Pg.2829]    [Pg.843]    [Pg.200]    [Pg.221]    [Pg.221]    [Pg.27]    [Pg.451]    [Pg.240]    [Pg.205]    [Pg.440]    [Pg.52]    [Pg.245]    [Pg.103]    [Pg.138]    [Pg.35]    [Pg.35]    [Pg.40]    [Pg.61]    [Pg.153]    [Pg.153]    [Pg.156]    [Pg.157]    [Pg.157]    [Pg.159]    [Pg.251]    [Pg.280]    [Pg.523]    [Pg.585]    [Pg.587]    [Pg.715]    [Pg.960]    [Pg.1108]    [Pg.49]    [Pg.429]    [Pg.159]    [Pg.37]    [Pg.31]    [Pg.170]    [Pg.277]    [Pg.419]    [Pg.45]    [Pg.58]    [Pg.168]   
See also in sourсe #XX -- [ Pg.53 ]

See also in sourсe #XX -- [ Pg.56 ]

See also in sourсe #XX -- [ Pg.4 , Pg.23 ]

See also in sourсe #XX -- [ Pg.271 , Pg.285 , Pg.297 ]

See also in sourсe #XX -- [ Pg.138 ]

See also in sourсe #XX -- [ Pg.242 , Pg.372 ]

See also in sourсe #XX -- [ Pg.112 ]

See also in sourсe #XX -- [ Pg.204 ]

See also in sourсe #XX -- [ Pg.242 , Pg.243 , Pg.248 , Pg.253 , Pg.256 , Pg.260 ]

See also in sourсe #XX -- [ Pg.919 , Pg.920 , Pg.921 ]

See also in sourсe #XX -- [ Pg.4 ]

See also in sourсe #XX -- [ Pg.435 ]

See also in sourсe #XX -- [ Pg.353 ]




SEARCH



Antibodies ligand-binding assays

Application of Automation in Ligand-Binding Assays

Assay cellulose filter binding

Assays binding anti-drug antibodies

Automation in ligand binding assays

Avidin, biotin binding affinity assay

Binding Assays with Membranes

Binding assay description

Binding assay development

Binding assay membrane

Binding assay optimization

Binding assay procedure

Binding assay purpose

Binding assay with soluble proteins

Binding assays biotin

Binding assays cobalamins

Binding assays folates

Binding competition assays

Binding-Inhibition assay

Bioassays protein binding assays

Bradford protein assay binding assays

Cell-free competition binding assay

Combinatorial peptide library binding assay

Competitive binding assay

Competitive binding assay Immunoassay

Competitive binding assay principle

Competitive ligand binding assays

Competitive protein binding assay

Covalent binding assay

Critical Future Challenges for Ligand-Binding Assays

Development and Validation of Ligand-Binding Assays for Biomarkers

Development of Radioligand Binding Assays

Direct binding assays

Drug binding assays, protein

Drug physicochemical binding assays

ELISA direct binding assay

ER binding assay

Electrochemiluminescence-Based Ligand-Binding Assays

Endothelial cells binding assay

Enzyme assay direct binding

Enzyme protein binding assay

Equilibrium dialysis protein binding assays

Estrogen receptor binding assays

Estrogen receptor competitive binding assays

Filter binding assay

Filter binding radioactivity assays

Flow injection binding assays

Forward-affinity binding assay

GTP binding assay

GTPy binding assay

Hybridization based ligand binding assays

In Vitro Binding Assays

In vitro receptor- binding assays

Ligand Binding Assay Bioanalytical Focus

Ligand Binding Assay Bioanalytical Focus Group

Ligand binding assay

Ligand binding assay calibration curves

Ligand binding assay defined

Ligand binding assay development

Ligand binding assay disposition

Ligand binding assay linearity

Ligand binding assay macromolecules

Ligand binding assay methods

Ligand binding assay molecularly imprinted polymers

Ligand binding assay precision

Ligand binding assay specificity

Ligand binding assay spectrometry

Ligand binding assay standards

Ligand binding assay statistical validation

Ligand binding assay support

Ligand binding assay support specificity

Ligand binding assay surface plasmon resonance

Ligand cellular protein binding assays

Ligand-Binding Assay Bioanalytical Focus Group of AAPS

Ligand-Binding Assays Immunoassays

Ligand-Binding Assays to Support Disposition Studies of Macromolecular Therapeutics

Lipid-binding assay

MS Binding Assays

MS Binding Assays Quantifying the Bound Marker

MS Binding Assays Quantifying the Nonbound Marker

Neonicotinoids binding assay

Nonspecific binding , assay blocking

Nonspecific binding , assay blocking solution

On-bead binding assays

Opioid binding assays

Optimization and Validation Total Binding Antibody Assays

P-Opioid receptor radioligand binding assay

Performance characteristics, ligand binding assays

Plasma protein binding assays

Plate-based binding assays

Protein binding assays

Protein binding assays, radioisotopic

Protein kinase family binding assays

Radio-ligand binding assay

Radioligand binding assay

Radioligand binding assays imprinted polymer beads

Radioligand binding assays, problems

Radioligand binding assays, use

Radioligand competitive binding assay

Radioligand-displacement binding assay

Receptor binding assay activity

Receptor binding assay mouse vas deferens

Receptor binding assays

Receptor binding assays fundamentals

Receptor binding assays saturability

Receptor binding assays specificity

Receptor-ligand binding assay

Retinoid receptors ligand-binding assay

Retinol-binding protein assay

Reverse-affinity binding assay

Sensitivity total binding antibody assays

Serum protein binding assay

Solid-phase binding assays

Specific Ligand-Binding Assay Automation Systems

Specificity total binding antibody assays

Statistical Considerations in the Validation of Ligand-Binding Assays

Surface Plasmon Resonance Binding Assays

Systems for Ligand Binding and Enzyme Inhibition Assays Based on Mass Spectrometry

Thyroid hormone receptor binding assay

Total binding antibody assays

Total binding assay procedure

Validation ligand binding assays

© 2024 chempedia.info